These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Progress toward developing a cytomegalovirus vaccine. Marshall GS; Plotkin SA Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034 [TBL] [Abstract][Full Text] [Related]
4. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181 [TBL] [Abstract][Full Text] [Related]
5. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376 [TBL] [Abstract][Full Text] [Related]
6. The status of cytomegalovirus vaccine. Starr SE; Friedman HM; Plotkin SA Rev Infect Dis; 1991; 13 Suppl 11():S964-5. PubMed ID: 1664136 [TBL] [Abstract][Full Text] [Related]
7. Current prospects for immunization against cytomegaloviral disease. Adler SP Infect Agents Dis; 1996 Jan; 5(1):29-35. PubMed ID: 8789597 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547 [TBL] [Abstract][Full Text] [Related]
9. [The prevention of cytomegalovirus infection and disease by administration of biological products]. Ihara T Nihon Rinsho; 1998 Jan; 56(1):145-50. PubMed ID: 9465680 [TBL] [Abstract][Full Text] [Related]
10. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Schleiss MR; Heineman TC Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251 [TBL] [Abstract][Full Text] [Related]